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Clinical Manifestations
Aortic Stenosis
Meredith Kanet, RN, BSN
Introduction
• Aortic	stenosis	is	becoming	more	prominent	as	the	average	lifespan	of	humans	increases.,	as	statistics	are	reporting	that	greater than	4%	of	Americans	and	Europeans	over	the	age	of	75	years	old	are	directly	impacted	by	some	degree	of	aortic	stenosis	(Cary	&	Pearce,	2013).	
• In	aortic	stenosis,	narrowing	of the	aortic	valve	causes	some	degree	of	obstruction	in	blood	flow	from	the	left	ventricle	to	the	aorta often	brought	on	by	three	causes:	calcium	degeneration	seen	in	aging,	congenital	bicuspid	valve,	and	inflammatory	damage	from	rheumatic	heart	disease	(McCance	et	al.,	2014).
• As	a	nurse	working	in	a	cardiac	intensive	care	unit	frequently	caring	for	patients	with	aortic	stenosis,	it	is	imperative	that	proper	education	on	the	topic	of	aortic	stenosis	is	performed.	Whether	it	be	a	community	event,	doctor’s	office,	or	hospital	setting,	education	and	awareness	of	aortic	stenosis	can	lead	to	saving	lives	and	improved	quality	of	life.
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• Severity of aortic stenosis is equivalent	to	morbidity	and	mortality	rates.	The	more	severe	the	aortic	stenosis,	the	higher	risk	of	morbidity	and	mortality	(Obasare	et	al.,	2017).
• According	to	Treibel	et	al.	(2018),	aortic	stenosis	is	a	slow	and	progressive	with	major	impacts	on	the	left	ventricle	leading	to	left	ventricular	hypertrophy	(LVH)	and	”afterload-induced	heart	failure.”
• LVH	develops	as	a	compensatory	mechanism,	in	effort	to	maintain	cardiac	output	and	stroke	volume,	from	the	increase	in	afterload	that	occurs	as	the	aortic	valve	stenosis	worsens	in	severity.	As	a	result,	LVH	places	additional	strain	on	the	heart	causing	a	decrease	in	the	elasticity	of	the	heart	muscle	during	contractions	also	causing	a	decrease	in	blood	to	the	coronaryarteries	and	“increased	myocardial	workload,	oxygen	consumption,	and	mortality”	(Cary	&	Pearce,	2013).	
• Decreased blood	flow	to	the	coronary	arteries	places	patients	at	a	higher	risk	for	myocardial	ischemia	and	infarction.
• Associated	reliance	on	atrial	kick	to	maintain	stroke	volume	and	cardiac	output	occurs	and	“loss	or	compromise	of	atrial	kick	as	a	results	of	atrial	fibrillation,	ventricular	pacing,	and/or	intravascular	fluid	volume	overload	may	precipitate	pulmonary	congestion,	hypotension,	and	angina”	(Cary	&	Pearce,	2013).	
Treatment Options
Figure 1. Comparison	of	normal	aortic	valve	vs.	stenotic	
aortic	valve	(University	of	Michigan	Frankel	
Cardiovascular	Center,	2018).	
Table 1. Diagnostic Studies	in	Aortic	Stenosis	(Cary & Pearce, 2013).	
• The	most	common	cause	of	aortic	stenosis	is	related	to	calcium	build	up	on	the	aortic	valve	leaflets.	There	are	two	different	mechanisms	in which thismay	occur:1)	“Mechanical	stress	or	disease	causes				valvular	interstitial	cells	within	the	valve	leaflets	to	transform	from	the	usual	state	of	maintenance	and	repair	into	an	activated	state	in	which	cell	proliferation	is	increased	and	myofibroblasts	and	osteoblasts	develop,	promoting	calcification,	osteogenesis,	and	bone	formation”	(Cary	&	Pearce,	2013).2) “Mechanical	stress	associated	with	blood	crossing	the	aortic	valve	damages	the	basement	membrane	of	the	leaflets,	allowing	entry	and	accumulation	of	T	lymphocytes,	monocytes,	and	low-density	lipoprotein	that	then	initiate	inflammation	and	oxidation	of	the	lipoprotein”	(Cary	&	Pearce,	2013).
• Calcium	deposition	that	accumulates	on	the	aortic	valve	leaflets	through cellularmanifestations	“bulge	outward	toward	the	aorta	and	extend	to	the	sinuses	of	Valsalva,	causing	restricted leafletmotion and obstruction of leftventricular outflow during systole”(Cary & Pearce,	2013).	
• Due to the increased stress placed on a	congenital	bicuspid aortic	valve,	aortic	stenosis	often	occurs	at	an	earlier	age	(Cary	&	Pearce,	2013).
Surgical	Aortic	Valve	Replacement	(SAVR)
• Standard treatment of choice for patient’s withsevere aortic stenosis able to tolerate the risks ofgeneral anesthesia and the post-operativerehabilitation	process following a sternotomy.
• Surgery	involves open sternotomy	and	cardio-pulmonary	bypass	with	the	surgeon	cutting	out	the	stenotic	aortic	valve	and	permanently	placing	a	new	valve	deemed	the	best	fit	for	the	patient	based	off	of		pre-operative	testing.
• Valve replacement may be done with	a	bi-leaflet	mechanical	valve	(requires	lifelong	anticoagulation	therapy)	or	an	engineered	tissue	prosthetic	valve	made	from	bovine	or	porcine	pericardial	tissue	(typically	does	not	require	anticoagulation	therapy	long-term).	Valve	type	is	selected	based	on	the	age,	co-morbidities,	and	lifestyle	of	the	patient	(Dobson,	Fairbairn,	Plein, & Greenwood, 2015).Transcatheter	Aortic	Valve	Replacement	(TAVR)
• Procedural	alternative	available	for	patients	with	severe,	often-symptomatic,	aortic	stenosis	deemed	to	be	too	high-risk	for	SAVR.
• Criteria	for	TAVR	include:	severe	and	symptomatic	aortic	stenosis,	deemed	too	high risk for	SAVR	by	twophysicians,	and	have	a	predicted	greater	than	one	year	survival	rate	post-procedure	(O’Sullivan	&	Wenaweser,	2017).
• Performed	by	interventional	cardiologists	with	a	surgeon	on	stand-by.	Using	a	femoral,	subclavian,	or	apical	approach,	a	new	prosthetic	tissue	valve	isdeployed by a catheter over	the existing	stenotic	valve	while	the	patient’s	heart	is	still	beating	(Dobson	et	al.,	2015).Aortic	Valvuloplasty
• Performed in the cardiac cath lab by aninterventional cardiologist.	Often	done	interim	in	high	risk	cases	until	physicians	can	plan	for	SAVR	vs	TAVR	or	palliatively	(Eltchaninoff	et	al.,	2014).Medical	Management
• No true	medication	therapy	is	available	to	treat orcease the progression of aortic stenosis	(Pawade,	Newby,	&	Dweck,	2015).
•
• Shortness of breath	and/or	dyspnea	on	exertion
• Decreased level of activity tolerance
• Fatigue
• Chest pain
• Dizziness/lightheadedness
• Decreased systolic	blood	pressure
• Pulsus paradoxus
• Heart	murmur
• Heart	failure*Some	patients	may	be	asymptomatic	up	to	the	point	of	severe	aortic	stenosis	*(Cary	&	Pearce,	2013)
Asymptomatic	Aortic	Stenosis	Management
• Strict	blood	pressure	control- hypertension	can	place increased workload on a heartwith LVH.	Vasodilators	such as ACEinhibitors or ARBs are the drugs of choice.	Beta	blockers	are	used	cautiously	unless	needed	for	arrhythmia	management	
• Monitor	for hypotension-can	induce	heart	failure	in	patients	with	aortic	stenosis
• Monitor for orthostatic hypotension
• Balanced	ratio	between	rest	and	activity
• Encourage good oral care practices to avoid	endocarditis	on	aortic	valve(Cary	&	Pearce,	2013)Symptomatic	Aortic Stenosis Management
• “For	patients	who	do	not	have	surgicalrepair,	medical	management	of	angina,	exertional	syncope,	and	signs	and	symptoms	of	heart	failure	becomes			necessary” (Cary & Pearce, 2013).
• Use of a pulmonary artery (PA) catheter	is	necessary	to	titrate	intravenous	(IV)	drugs	helpful	in	maintaining	adequate	preload,	afterload,	and	contractility.	
• Diuretic therapy may be used to combat	a	heart	failure	exacerbation-monitoring	adequate	fluid	volume	to	prevent	excessive	shifts	of	fluid	that	could	affect	a	patient’s	hemodynamic	status(Cary & Pearce, 2013)
• Aortic	stenosis	is	a	growing	problem	as	humans	are	living	longer
• Can	be	potentially	fatal	if	left	untreated.	“After	onset,	without	surgical	intervention,	the	mean	life	expectancy	is	2	to	3	years”	(Cary	&	Pearce,	2013).
• Diagnostic studies are widely available	to help assess	the	presence	and	severity	of	aortic	stenosis
• Management	of symptoms associatedwith severe aortic stenosis is critical	in	an	intensive	care	setting	until	surgical	intervention	can	occur
• Surgical	interventions	are	available	with	good	outcomes	for	life	expectancy	if	patients	meet	criteria
• In	an	acute	care	setting,	“goals	in	patients’	daily	plan	of	care	include	balancing	rest	and	activity	to	maintain	oxygen	supply	and	demand	and	maintaining	heart	rate,	blood	pressure,	temperature,	and	fluid	volume	status	within	reference	ranges”	(Cary	&	Pearce,	2013).	
